These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 21420032)

  • 1. MicroRNAs as therapeutic targets in cancer.
    Nana-Sinkam SP; Croce CM
    Transl Res; 2011 Apr; 157(4):216-25. PubMed ID: 21420032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs and cancer stem cells: the sword and the shield.
    Sun X; Jiao X; Pestell TG; Fan C; Qin S; Mirabelli E; Ren H; Pestell RG
    Oncogene; 2014 Oct; 33(42):4967-77. PubMed ID: 24240682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of microRNAs in ovarian function and the transition toward novel therapeutic strategies in fertility preservation: from bench to future clinical application.
    Alexandri C; Daniel A; Bruylants G; Demeestere I
    Hum Reprod Update; 2020 Feb; 26(2):174-196. PubMed ID: 32074269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in the pathogenesis of Lung Cancer.
    Wu X; Piper-Hunter MG; Crawford M; Nuovo GJ; Marsh CB; Otterson GA; Nana-Sinkam SP
    J Thorac Oncol; 2009 Aug; 4(8):1028-34. PubMed ID: 19474765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs as therapeutic targets in human cancers.
    Shah MY; Calin GA
    Wiley Interdiscip Rev RNA; 2014; 5(4):537-48. PubMed ID: 24687772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting microRNAs in pancreatic cancer: microplayers in the big game.
    Khan S; Ansarullah ; Kumar D; Jaggi M; Chauhan SC
    Cancer Res; 2013 Nov; 73(22):6541-7. PubMed ID: 24204026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.
    Corsini LR; Bronte G; Terrasi M; Amodeo V; Fanale D; Fiorentino E; Cicero G; Bazan V; Russo A
    Expert Opin Ther Targets; 2012 Apr; 16 Suppl 2():S103-9. PubMed ID: 22443195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Principles of microRNA involvement in human cancers.
    Ling H; Zhang W; Calin GA
    Chin J Cancer; 2011 Nov; 30(11):739-48. PubMed ID: 22035854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-coding RNAs in cancer initiation and progression and as novel biomarkers.
    Nana-Sinkam SP; Croce CM
    Mol Oncol; 2011 Dec; 5(6):483-91. PubMed ID: 22079056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs, Long Noncoding RNAs, and Their Functions in Human Disease.
    Xue M; Zhuo Y; Shan B
    Methods Mol Biol; 2017; 1617():1-25. PubMed ID: 28540673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers.
    Barwal TS; Sharma U; Bazala S; Singh I; Jain M; Prakash H; Shekhar S; Sandberg EN; Bishayee A; Jain A
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in clinical oncology: at the crossroads between promises and problems.
    Metias SM; Lianidou E; Yousef GM
    J Clin Pathol; 2009 Sep; 62(9):771-6. PubMed ID: 19734473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in cancer diagnosis and therapy: from bench to bedside.
    Hoshino I; Matsubara H
    Surg Today; 2013 May; 43(5):467-78. PubMed ID: 23129027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic potential of microRNAs in cancer.
    Thorsen SB; Obad S; Jensen NF; Stenvang J; Kauppinen S
    Cancer J; 2012; 18(3):275-84. PubMed ID: 22647365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA dysregulation in cancer: opportunities for the development of microRNA-based drugs.
    Nana-Sinkam SP; Croce CM
    IDrugs; 2010 Dec; 13(12):843-6. PubMed ID: 21154140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
    Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
    Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathways: microRNAs as cancer therapeutics.
    Melo SA; Kalluri R
    Clin Cancer Res; 2012 Aug; 18(16):4234-9. PubMed ID: 22711704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application.
    Nana-Sinkam SP; Croce CM
    Cancer Genet Cytogenet; 2010 Dec; 203(2):127-33. PubMed ID: 21156224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer.
    Tang S; Li S; Liu T; He Y; Hu H; Zhu Y; Tang S; Zhou H
    Cancer Lett; 2021 Apr; 502():71-83. PubMed ID: 33453304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and therapeutic role of microRNAs in oral cancer (Review).
    Wang J; Lv N; Lu X; Yuan R; Chen Z; Yu J
    Oncol Rep; 2021 Jan; 45(1):58-64. PubMed ID: 33200230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.